41 results
Page 2 of 3
6-K
EX-1.1
l4ne2b4yo2kx9of
26 Feb 20
Enlivex Therapeutics Closes $8.0 Million Registered Direct Offering
4:15pm
20-F/A
qjz499d1b5yg7llne7x7
23 Jan 20
Annual report (foreign) (amended)
4:31pm
424B3
aout 82t8t077
10 Jul 19
Prospectus supplement
8:18am
F-3
1d6nxoq9fa6t qmr
28 Jun 19
Shelf registration (foreign)
9:48am
6-K
EX-99.1
ew7lw0ho0pzhtojy
27 Mar 19
Securities Purchase Agreement
8:32am
6-K
EX-99.6
2h1j59ue1y b7l
27 Mar 19
Securities Purchase Agreement
8:32am
6-K
wtx8cw8dvr6qn
27 Mar 19
Securities Purchase Agreement
8:32am
6-K
EX-99.2
ztzdbd bv67z6hxckeqk
6 Dec 18
Amended Notice of Annual and Extraordinary General Meeting of the Shareholders
4:43pm
6-K
EX-99.1
nlnf4k 8r77wckk2w
19 Nov 18
Agreement and Plan of Merger
4:34pm
6-K
EX-99.1
vvv72sp768o
26 Jul 18
Bioblast Pharma Ltd. Corporate and Management Update
4:35pm
6-K
EX-99.1
1k5detuts7vmfgv8
18 Apr 17
Current report (foreign)
12:00am
6-K
EX-99.1
sfec5bfq
27 Oct 15
Current report (foreign)
12:00am
20-F
knbp2lzbfvg
31 Mar 15
Annual report (foreign)
12:00am
6-K
EX-99.1
vkh 2wls0eutbmptw
23 Sep 14
Notice of Extraordinary General Meeting of Shareholders
12:00am
424B4
ss5q4bc7pi jz0
31 Jul 14
Prospectus supplement with pricing info
12:00am